Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander Trenson

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Life Science Alliance|September 20, 2024
PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fatesJore Van Wauwe, Alexia Mahy, Sander Craps, et al.
Scientific Reports|June 20, 2018
Molecular signature of progenitor cells isolated from young and adult human heartsAnn-Sophie Walravens, Maarten Vanhaverbeke, Lara Ottaviani, et al.
European Journal of Heart Failure|October 31, 2023
Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysisSander Trenson, Gabor Voros, Pieter Martens, et al.
Nature Communications|November 3, 2017
MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitorsGiorgia Giacomazzi, Bryan Holvoet, Sander Trenson, et al.
The Lancet. Healthy Longevity|November 12, 2021
Urinary peptidomic profiles to address age-related disabilities: a prospective population studyDries S Martens, Lutgarde Thijs, Agnieszka Latosinska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general populationFang-Fei Wei, Sander Trenson, Lutgarde Thijs, et al.
ESC Heart Failure|July 30, 2025
Patient-specific modifiers of survival benefit in cardiac resynchronization therapy - A multicentre interaction analysisBert Vandenberk, Marius Brusselmans, Gabor Voros, et al.
Journal of Clinical Medicine|April 13, 2024
Landmark Evolutions in Time and Indication for Cardiac Resynchronization Therapy: Results from a Multicenter Retrospective RegistryJeroen Bijnens, Sander Trenson, Gabor Voros, et al.
Journal of the American College of Cardiology|May 11, 2019
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureChandan K Nagaraju, Emma L Robinson, Mouna Abdesselem, et al.
ESC Heart Failure|July 12, 2020
Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus: a long-term retrospective cohort studyPeter C Kahr, Sander Trenson, Matthias Schindler, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Life Science Alliance|September 20, 2024
PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fatesJore Van Wauwe, Alexia Mahy, Sander Craps, et al.
Scientific Reports|June 20, 2018
Molecular signature of progenitor cells isolated from young and adult human heartsAnn-Sophie Walravens, Maarten Vanhaverbeke, Lara Ottaviani, et al.
European Journal of Heart Failure|October 31, 2023
Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysisSander Trenson, Gabor Voros, Pieter Martens, et al.
Nature Communications|November 3, 2017
MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitorsGiorgia Giacomazzi, Bryan Holvoet, Sander Trenson, et al.
The Lancet. Healthy Longevity|November 12, 2021
Urinary peptidomic profiles to address age-related disabilities: a prospective population studyDries S Martens, Lutgarde Thijs, Agnieszka Latosinska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general populationFang-Fei Wei, Sander Trenson, Lutgarde Thijs, et al.
ESC Heart Failure|July 30, 2025
Patient-specific modifiers of survival benefit in cardiac resynchronization therapy - A multicentre interaction analysisBert Vandenberk, Marius Brusselmans, Gabor Voros, et al.
Journal of Clinical Medicine|April 13, 2024
Landmark Evolutions in Time and Indication for Cardiac Resynchronization Therapy: Results from a Multicenter Retrospective RegistryJeroen Bijnens, Sander Trenson, Gabor Voros, et al.
Journal of the American College of Cardiology|May 11, 2019
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureChandan K Nagaraju, Emma L Robinson, Mouna Abdesselem, et al.
ESC Heart Failure|July 12, 2020
Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus: a long-term retrospective cohort studyPeter C Kahr, Sander Trenson, Matthias Schindler, et al.
Pageof 6